摘要
目的:观察鼻内窥镜下泪道浚通联合硅胶管逆行植入和丝裂霉素C(MMC)应用治疗泪道阻塞的手术疗效。方法:鼻内窥镜下利用泪道浚通联合类Y形硅胶管规范泪道逆行植入和MMC应用,留置Y形管3mo,跟踪观察并统计其中106例106眼的治疗结果。结果:鼻内窥镜下泪道浚通后MMC应用,置留、拔管操作特别简单容易,创伤甚微。全部治疗在门诊完成,期间患者正常生活、工作、学习。3a以上随访治疗结果:有效以上率96.2%(102眼);显效以上率92.5%(98眼);治愈率84.9%(90眼);无效3.8%(4眼)。结论:鼻内窥镜下泪道浚通联合硅胶管逆行植入和MMC应用技术是治疗泪道阻塞的首选与补充方法,损伤小,成功率高,并发症少,手术费用低。
AIM： To investigate the surgery effect of lacrimal passages dredging,silicon tube implantation and mitomycin C （MMC） retrograde treatment by endoscopy for lacrimal duct obs-truction. METHODS： Totally 106 cases underwent the lacrimal passages dredging, Y-shaped silicon tube implantation, and mitomycin C application after 3 months, and the surgery effect were observed. RESULTS： Lacrimal passages dredging, silicon tube implantation and mitomycin C retrograde treatment by endoscopy extubation, the operation had easy procedure, and very little trauma. A normal life, work, study were recorded. Following-up 3 years： the effective rate of 96.2% or more were in 102 eyes, marked effect accounted for92.5% （98 eyes）, cure rate was in 90 eyes （84.9%） and invalid in 4 eyes （3.8%）. CONCLUSION： The above technique is the preferred and supplementary treatment method for lacrimal duct obstruction, which also have less damage, higher success rate, fewer complications and lower operation costs.
出处
《国际眼科杂志》
CAS
2010年第10期2028-2029,共2页
International Eye Science
关键词
鼻内窥镜
泪道浚通
Y形硅胶管逆行植入
泪道阻塞
丝裂霉素C
应用
endoscopy
lacrimal duct dredging
Yshaped silicone tube retrograde implantation
lacrimal duct obstruction
mitomycin C
application
